MedTrace Logo

Interaction Between Fluvoxamine and Sildenafil

NCT00175981 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2005-09-15

No results posted yet for this study

Summary

Aim of the study is to assess the interaction between sildenafil and fluvoxamine and its effect on the venous response to sodium nitroprusside.

Conditions

  • Healthy

Interventions

DRUG

sildenafil, fluvoxamine

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Walter E Haefeli, MD · Heidelberg University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-02-28
Completion
2004-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00175981 on ClinicalTrials.gov